| Inexpensive |
27 |
| Long-term persistence of immunogenicity |
19 |
| Subunit vaccination with no risk for infection |
28 |
| Antigen presentation by both MHC class I and class II molecules |
28 |
| Ability to polarize T-cell help toward type 1 or type 2 |
28 |
| Ease of development and production |
27,28 |
| Immune response focused only on antigen of interest |
23 |
| Stability of vaccine for storage and shipping |
25 |
|
In vivo expression ensures that the protein resembles the normal eukaryotic structure more closely, with accompanying post-translational modifications |
19 |
| DNA vaccines are safer, more stable, and easy to handle |
29 |
| DNA vaccines induce protective humoral and cellular immune responses |
30 |
| DNA vaccines are heat stable |
27 |
| A mixture of plasmids could be used to form a broad spectrum vaccine |
25 |
